Similarly, post-treatment with GLP-1R agonists rescues aberrant cytotoxicity and impaired viability, and further enhances cell survival signalling to protect SH-SY5Y neuroblastoma cells from chronic rotenone-induces oxidative stress19. This evidence concerns the gene GLP1R and neuroblastoma.